WGU D116 PA EXAM /APPROVED
WGU D116 ADVANCED
PHARMACOLOGY PRE
ASSESSMENT EXAM ACTUAL 2026
WGU D116 PA EXAM /APPROVED WGU D116 | Comprehensive
Examination
WGU D116 PA EXAM /APPROVED WGU D116
ADVANCED PHARMACOLOGY PRE ASSESSMENT
EXAM ACTUAL 2026 /2027 PREMIUM PRACTICE
INTRODUCTION
This document is an important and very helpful preparation
resource for WGU D116 PA EXAM /APPROVED WGU D116
ADVANCED PHARMACOLOGY PRE ASSESSMENT EXAM
ACTUAL 2026 /2027 PREMIUM PRACTICE QUESTIONS
AND STUDY GUIDE ACCURATE EXAM COMPLETE REA
L
QUESTIONS AND CORRECT DETAILED ANSWERS WITH
RATIONALES (100% CORRECT VERIFIED SOLUTION.
Every item uses a focused exam stem, four response options, a
keyed response, and a clear rationale, making it easier to
understand the subject, spot distractors, and build real exam
confidence.
Page 1
, Question 1
A patient on chronic warfarin therapy is prescribed
trimethoprim-sulfamethoxazole for a urinary tract infection. Which mechanism
best explains the anticipated rise in INR?
A. Inhibition of CYP2C9-mediated metabolism of S-warfarin
B. Induction of CYP3A4 leading to increased warfarin clearance
C. Displacement of warfarin from albumin binding sites without
metabolic change
D. Enhanced renal tubular reabsorption of warfarin due to sulfonamide
competition
Correct Answer: A - Inhibition of CYP2C9-mediated metabolism
of S-warfarin
RATIONALE
Trimethoprim-sulfamethoxazole inhibits CYP2C9, the primary
enzyme metabolizing the more potent S-warfarin, increasing its
half-life and INR. While protein binding displacement occurs, it is
transient and not the primary mechanism; CYP3A4 induction would
lower INR, and renal reabsorption is not clinically significant.
Question 2
A patient with heart failure and reduced ejection fraction is initiated on
sacubitril/valsartan. Which concurrent medication requires immediate
discontinuation due to a black box warning?
A. Spironolactone
B. Carvedilol
C. Lisinopril
D. Furosemide
Correct Answer: C - Lisinopril
Page 2
, RATIONALE
Sacubitril/valsartan carries a black box warning for angioedema when
used concomitantly with ACE inhibitors; a 36-hour washout is
required. Spironolactone, carvedilol, and furosemide are commonly
used together safely in HFrEF management.
Question 3
Which statement accurately describes the pharmacodynamic consequence of a
partial agonist at the mu-opioid receptor?
A. It produces a maximal effect greater than that of a full agonist.
B. It produces a ceiling effect lower than that of a full agonist.
C. It competitively antagonizes endogenous opioids without intrinsic
activity.
D. It irreversibly binds to the receptor, permanently blocking analgesia.
Correct Answer: B - It produces a ceiling effect lower than that of
a full agonist.
RATIONALE
A partial agonist (e.g., buprenorphine) has intrinsic activity greater
than zero but less than a full agonist, resulting in a ceiling effect on
respiratory depression and analgesia. It does not exceed full agonist
efficacy, is not a pure antagonist, and binds reversibly.
Question 4
A patient with bipolar I disorder on lithium presents with coarse tremor, ataxia,
and serum lithium level of 2.1 mEq/L. Which intervention is the most
appropriate immediate step?
A. Administer activated charcoal
B. Initiate hemodialysis
C. Administer flumazenil
D. Increase sodium intake and monitor
Page 3
, Correct Answer: B - Initiate hemodialysis
RATIONALE
Lithium toxicity with severe neurologic symptoms and levels >2.0
mEq/L warrants hemodialysis, which effectively removes lithium.
Activated charcoal does not bind lithium, flumazenil is for
benzodiazepine reversal, and increasing sodium is supportive but
insufficient for severe toxicity.
Question 5
Which pharmacokinetic parameter is most directly altered by the induction of
hepatic cytochrome P450 enzymes?
A. Volume of distribution
B. Bioavailability of IV drugs
C. Clearance of substrate drugs
D. Protein binding affinity
Correct Answer: C - Clearance of substrate drugs
RATIONALE
Enzyme induction increases the metabolic clearance of substrate
drugs, reducing their half-life and plasma concentration. Volume of
distribution and protein binding are largely unaffected by CYP
induction, and IV bioavailability is always 100%.
Question 6
A patient with severe sepsis is started on vancomycin and
piperacillin-tazobactam. Which adverse effect is most associated with this
combination?
A. Acute kidney injury
B. Hepatotoxicity
C. QT prolongation
D. Peripheral neuropathy
Page 4
WGU D116 ADVANCED
PHARMACOLOGY PRE
ASSESSMENT EXAM ACTUAL 2026
WGU D116 PA EXAM /APPROVED WGU D116 | Comprehensive
Examination
WGU D116 PA EXAM /APPROVED WGU D116
ADVANCED PHARMACOLOGY PRE ASSESSMENT
EXAM ACTUAL 2026 /2027 PREMIUM PRACTICE
INTRODUCTION
This document is an important and very helpful preparation
resource for WGU D116 PA EXAM /APPROVED WGU D116
ADVANCED PHARMACOLOGY PRE ASSESSMENT EXAM
ACTUAL 2026 /2027 PREMIUM PRACTICE QUESTIONS
AND STUDY GUIDE ACCURATE EXAM COMPLETE REA
L
QUESTIONS AND CORRECT DETAILED ANSWERS WITH
RATIONALES (100% CORRECT VERIFIED SOLUTION.
Every item uses a focused exam stem, four response options, a
keyed response, and a clear rationale, making it easier to
understand the subject, spot distractors, and build real exam
confidence.
Page 1
, Question 1
A patient on chronic warfarin therapy is prescribed
trimethoprim-sulfamethoxazole for a urinary tract infection. Which mechanism
best explains the anticipated rise in INR?
A. Inhibition of CYP2C9-mediated metabolism of S-warfarin
B. Induction of CYP3A4 leading to increased warfarin clearance
C. Displacement of warfarin from albumin binding sites without
metabolic change
D. Enhanced renal tubular reabsorption of warfarin due to sulfonamide
competition
Correct Answer: A - Inhibition of CYP2C9-mediated metabolism
of S-warfarin
RATIONALE
Trimethoprim-sulfamethoxazole inhibits CYP2C9, the primary
enzyme metabolizing the more potent S-warfarin, increasing its
half-life and INR. While protein binding displacement occurs, it is
transient and not the primary mechanism; CYP3A4 induction would
lower INR, and renal reabsorption is not clinically significant.
Question 2
A patient with heart failure and reduced ejection fraction is initiated on
sacubitril/valsartan. Which concurrent medication requires immediate
discontinuation due to a black box warning?
A. Spironolactone
B. Carvedilol
C. Lisinopril
D. Furosemide
Correct Answer: C - Lisinopril
Page 2
, RATIONALE
Sacubitril/valsartan carries a black box warning for angioedema when
used concomitantly with ACE inhibitors; a 36-hour washout is
required. Spironolactone, carvedilol, and furosemide are commonly
used together safely in HFrEF management.
Question 3
Which statement accurately describes the pharmacodynamic consequence of a
partial agonist at the mu-opioid receptor?
A. It produces a maximal effect greater than that of a full agonist.
B. It produces a ceiling effect lower than that of a full agonist.
C. It competitively antagonizes endogenous opioids without intrinsic
activity.
D. It irreversibly binds to the receptor, permanently blocking analgesia.
Correct Answer: B - It produces a ceiling effect lower than that of
a full agonist.
RATIONALE
A partial agonist (e.g., buprenorphine) has intrinsic activity greater
than zero but less than a full agonist, resulting in a ceiling effect on
respiratory depression and analgesia. It does not exceed full agonist
efficacy, is not a pure antagonist, and binds reversibly.
Question 4
A patient with bipolar I disorder on lithium presents with coarse tremor, ataxia,
and serum lithium level of 2.1 mEq/L. Which intervention is the most
appropriate immediate step?
A. Administer activated charcoal
B. Initiate hemodialysis
C. Administer flumazenil
D. Increase sodium intake and monitor
Page 3
, Correct Answer: B - Initiate hemodialysis
RATIONALE
Lithium toxicity with severe neurologic symptoms and levels >2.0
mEq/L warrants hemodialysis, which effectively removes lithium.
Activated charcoal does not bind lithium, flumazenil is for
benzodiazepine reversal, and increasing sodium is supportive but
insufficient for severe toxicity.
Question 5
Which pharmacokinetic parameter is most directly altered by the induction of
hepatic cytochrome P450 enzymes?
A. Volume of distribution
B. Bioavailability of IV drugs
C. Clearance of substrate drugs
D. Protein binding affinity
Correct Answer: C - Clearance of substrate drugs
RATIONALE
Enzyme induction increases the metabolic clearance of substrate
drugs, reducing their half-life and plasma concentration. Volume of
distribution and protein binding are largely unaffected by CYP
induction, and IV bioavailability is always 100%.
Question 6
A patient with severe sepsis is started on vancomycin and
piperacillin-tazobactam. Which adverse effect is most associated with this
combination?
A. Acute kidney injury
B. Hepatotoxicity
C. QT prolongation
D. Peripheral neuropathy
Page 4
